AMY-301

N/A

Report date: 2024/11/07 16:30:28
NME

Base Information

Drug NameAMY-301
Drug Alias NameAMY-301
ClassificationSmall molecules
Mechanisms of ActionComplement factor H stimulants
TargetsComplement factor H
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAmyndas Pharmaceuticals Sa
China Registration ClassN/A

Develop Information

Active CompaniesAmyndas Pharmaceuticals Sa
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A